Pyrrolidine glycosidase inhibitors
US12016852B2 · kind B2 · utility
4Cited by
23References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2019 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Jun 28, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) wherein A, W, R3b, Z and p have the meaning according to the claims, can be employed, inter alia, for the treatment of taupathies and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.